LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Capricor Therapeutics (OTCBB: CAPR) (a subsidiary of Nile Therapeutics; aka Capricor)

1-Allogeneic cardiac-derived cells (CDCs) aimed at attenuating and potentially improving heart damage resulting from heart failure (HF) and 2-Dual nat....

Get a Demo and See the Full Profile

Get a demo today to see profiles of Capricor Therapeutics (OTCBB: CAPR) (a subsidiary of Nile Therapeutics; aka Capricor) plus 6123 other startups.

Learn More About Capricor Therapeutics (OTCBB: CAPR) (a subsidiary of Nile Therapeutics; aka Capricor)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More